Uptake of treatments approved by NICE and NHS England can sometimes be slower than expected, which is frustrating for clinicians, patients, and industry. What are the roadblocks? What can be done to overcome them? Our roundtable panel discusses the issues.
The process of getting new, expensive, and highly specialised treatments to patients will always be slightly convoluted and involve significant effort for healthcare professionals and industry. The various processes have been in a state of constant change for the last decade, making it even harder for those involved to navigate the system.
The good news is that all parties are trying to work together to improve new medicines uptake so that more patients can benefit from treatments sooner. However, this will take time, so Specialised Commissioning asked a panel of experts to identify the key, practical issues currently facing professionals and patients, and suggest ways of resolving them now and in the future.